Insider · CIK 0002079768
Christopher James Stevens
Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing Aug 13, 2026, latest Aug 13, 2026.
In brief
Christopher James Stevens files SEC Form 4 as COO at RCKT (ROCKET PHARMACEUTICALS, INC.). Since Aug 13, 2026, Christopher James Stevens has reported 0 open-market buys worth $0 and 1 open-market sell worth $128k, the latest filed on Aug 13, 2026.
A track record needs three past buys with six months of prices behind them; Christopher James Stevens has 0, so none is measured yet.
The newest scored trade: sold $128k of RCKT on Aug 11, 2026, filed Aug 13, 2026, scored 46 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $128k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RCKT: ROCKET PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | ROCKET PHARMACEUTICALS, INC. | $128k 36,658 shares | -7% | +35% from low-34% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 36,658 0.03% of outstanding | $128k | Aug 11, 2026 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -36,658 | $3.50 | $128k | 505,784 | Aug 13, 2026 |
| Aug 3, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +73,313 | $0.00 | $0 | 542,442 | Aug 5, 2026 |
| Aug 3, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +101,428 | $0.00 | $0 | 101,428 | Aug 5, 2026 |
| Feb 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +61,963 | $0.00 | $0 | 469,129 | Feb 13, 2026 |
| Feb 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +93,037 | $0.00 | $0 | 93,037 | Feb 13, 2026 |
| Aug 4, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +407,166 | $0.00 | $0 | 407,166 | Aug 6, 2025 |
| Aug 4, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +554,071 | $0.00 | $0 | 554,071 | Aug 6, 2025 |
Questions about Christopher James Stevens
Answered from the filings on this page, as of the latest one.
Is Christopher James Stevens buying or selling?
In the last 12 months Christopher James Stevens reported 0 open-market buys worth $0 and 1 open-market sell worth $128k on SEC Form 4; the latest was sold $128k of RCKT on Aug 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Christopher James Stevens's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher James Stevens has 0.
Where does Christopher James Stevens file Form 4?
Christopher James Stevens has filed Form 4 at RCKT (ROCKET PHARMACEUTICALS, INC.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.